Skip to main content
SpringerLink
Log in

Antidepressant use and suicidal behaviour after FDA warnings

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Several warnings of the increased risk of suicidality in children and adolescents taking antidepressants were issued by the US FDA in 2003 and 2004. In May 2007, the warnings were extended to include young adults.

References

  1. Lu CY, et al. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ : 18 Jun 2014. Available from: URL: http://dx.doi.org/10.1136/bmj.g3596.

  2. Geddes JR, et al. Communicating the harmful effects of medicines. BMJ : 18 Jun 2014. Available from: URL: http://dx.doi.org/10.1136/bmj.g4047.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antidepressant use and suicidal behaviour after FDA warnings. Reactions Weekly 1508, 4 (2014). https://doi.org/10.1007/s40278-014-1640-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-1640-9

Search

Navigation